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Physicians often focus on the somatic component of illness 
while emotional aspects are overlooked.[1] The reasons for this 
are usually valid. All the same emotional disorders require 
adequate consideration, as an emotional disorder (i) may 
frequently occur concomitantly with a somatic illness, or 
(ii) may present as a somatic disorder.[2-4]
Chronic diseases are often associated with symptoms of an 
emotional disorder. Chronic diseases are being considered 
seriously the world over, as conditions such as heart 
disease, stroke, and diabetes are leading causes of death in 
the U.S.[5] and other countries.[6] The association between 
chronic disease and unhealthy lifestyle choices is becoming 
increasingly apparent.[7] As a result, nonpharmacological 
therapies that change the lifestyle are being considered in the 
management of many chronic diseases.[8] Among them, yoga 
has been shown to have therapeutic benefits and is useful in 
stress reduction.[9]
A review, conducted by searching three electronic 
databases (Ovid Medline, PsycINFO, CINAHL), with yoga 
as the keyword, yielded 2349 articles published between 
1980 and 2007.[10] Among the articles, 861 considered yoga and 
chronic disease. The number of articles post-2007 is likely to 
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Abstract
Background: Chronic illness is commonly associated with anxiety and depression. Both anxiety 
and depression respond to yoga. However, there is no report on the association between 
the intensity and duration of yoga practice with the benefits seen. Aim: The present study 
was intended to determine whether the daily duration of yoga practice and the duration of 
experience in months would predict anxiety and depression, associated with chronic illness. 
Subjects and Methods: Seven hundred and sixty‑three volunteers with ages between 14 and 
86 years (group mean age standard deviation, 50.2 [14.2]) who attended a 7 day residential 
yoga camp in the north of India were included in this cross‑sectional study. All participants 
had chronic illnesses, which were under control with treatment, and which were categorized 
and are detailed. Participants were assessed for state anxiety scores using State‑Trait Anxiety 
Inventory and for anxiety with hospital anxiety and depression scale (HADS‑A), and depression 
was assessed using HADS‑D scores of the HADS. Linear multiple regression analyses were 
performed using PASW SPSS version 18.0 (Armonk, New York, U.S.) to determine how the 
daily and monthly duration of yoga practice could influence state anxiety, hospital anxiety and 
depression of the participants. Results: Yoga practice in months and the time spent practicing 
yoga each day significantly predict the level of state anxiety (P < 0.001, P = 0.03) and 
HAD‑A (P < 0.01, P < 0.01). The duration of yoga practice in months alone was a significant 
predictor of the HAD‑D (P < 0.01). Conclusions: The results suggest that the duration of 
yoga practice in months and daily practice in minutes predict anxiety associated with chronic 
illness. In contrast the duration of yoga practice in months alone, predicted depression scores.
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have increased. However, this article is referred to here, as it 
examined the importance of noting the frequency and duration 
of yoga sessions. The author, Yang (2007) stated that ‘the total 
dose of yoga training, which depends on both the duration 
and frequency of yoga sessions, also needs to be considered 
in evaluating and comparing yoga studies’.
As described earlier, chronic disease is often associated 
with an emotional component.[1] Two aspects of emotional 
disorders that clinically have the most relevance are anxiety 
and depression.[11] Both anxiety and depression have benefited 
through yoga practice.[12] The present study was conducted 
on participants who had already been practicing yoga but 
had self-elected to enroll for a yoga program as they had a 
somatic disorder.
The aim of the study was to determine whether there would be 
associations between duration or intensity of yoga practice and 
the anxiety and/or depression experienced by these participants 
who already had a chronic somatic disease.
Subjects and Methods
Seven hundred and sixty-three participants self-elected to 
enroll for 7 day yoga based stress management program. 
Statistical calculation of the sample size was not done prior 
to the experiment. However, post‑hoc analyses were carried 
out for the present study, with the sample size as 763 in each 
group. The power was calculated for the multiple linear 
regression of total time and time per day as a predictor of 
State-Trait Anxiety Inventory (STAI-S) using G* Power 
Software version 2.0 (University of Dusseldorf, Dusseldorf, 
Germany).[13] The adjusted R2 value was used, and an effect 
size of 0.028 (small) was found; however with a sample size 
of 763 (large) the power was 0.989. For HAD-A, the adjusted 
R2 value was used and an effect size of 0.25 (small) was found; 
however with a sample size of 763 (large) the power was 1.00 
and for HAD-D, the adjusted R2 value was used and an effect 
size of 0.009 (small) was found; however with a sample size of 
763 (large) the power was 0.6446. The α-level was set as 0.05.[14]
The program was held in a Residential Yoga Center in North 
India. Their ages ranged between 14 and 86 years (group mean 
standard deviation, 50.2 [14.2] years), 95% confidence 
interval (CI) ±1.01 (49.2, 51.2) and there were 260 females in 
the group. Recruitment was by advertisements in a television 
channel and a yoga magazine. To be included in the trial 
participants had to meet the following criteria (i) their chronic 
illness had to be under control through the use of conventional 
medicine or other remedies; verified by the appropriate tests, 
(ii) they had to be sufficiently physically and mentally healthy 
to perform the yoga techniques, and (iii) literate, to complete 
the questionnaires. Participants were excluded from the trial if 
they could not complete the questionnaires (n = 331, 30.3%). 
Participants were excluded due to incomplete or inadequately 
completed questionnaires. The details of the participants are 
provided in Table 1. The signed consent of all participants was 
obtained. The project was approved by the Patanjali Research 
Foundation Ethics Committee, in February 2014. The study was 
completed between February 2014 and April 2014.
Design
The study was a single time, cross-sectional assessment.
Assessments
All participants were given with three questionnaires to fill in. 
These were (i) STAI-the subsection for state anxiety,[15] (ii) the 
hospital anxiety and depression scale (HADS)[11] and (iii) a 
set of questions to determine the participants’ experience and 
daily duration of yoga practice.
State‑trait anxiety inventory
State anxiety was measured using a sub-scale of Spielberger’s 
STAI,[15] which contains 20 items used to describe the intensity 
Table 1: Baseline characteristics of the 763 participants
Characteristics Details
Age, gender
Group mean age (SD), years 50.2 (14.2)
Age range 14‑86
Gender: Male: female as actual values, % 503:260, 65.9:34.1
Years of education (%)
<10 years of education 2 (0.3)
10 years of education 224 (29.4)
≥12 years of education 333 (43.6)
≥17 years of education 181 (23.7)
No details (%) 23 (3.0)
Annual income[50] (%)
Low class 264 (34.6)
Middle class 255 (33.4)
High class 6 (0.8)
No details 238 (31.2)
Diseases (blocks,[51] number) %
Certain infectious and parasitic diseases A00‑B99, 7 (0.9)
Neoplasms C00‑D48, 8 (1.1)
Diseases of the blood and blood‑forming 
organs and certain disorders involving the 
immune mechanism
D50‑D89, 10 (1.3)
Endocrine, nutritional and metabolic diseases E00‑E90, 103 (13.5)
Diseases of the nervous system G00‑G99, 33 (4.3)
Diseases of the eye and adnexa H00‑H59, 9 (1.2)
Diseases of the ear and mastoid process H60‑H95, 2 (0.3)
Diseases of the circulatory system I00‑I99, 82 (10.8)
Diseases of the respiratory system J00‑J99, 46 (6.0)
Diseases of the digestive system K00‑K93, 88 (11.5)
Diseases of the skin and subcutaneous 
tissue
L00‑L99, 9 (1.2)
Diseases of the musculoskeletal system 
and connective tissue
M00‑M99, 154 (20.2)
Diseases of the genitourinary system N00‑N99, 22 (2.9)
No details 190 (24.9)
Values are group mean (SD). SD: Standard deviation
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of feelings at the moment of testing. The participants had to 
choose one out of the four options provided for each item that 
is, not at all = 1, somewhat = 2, moderately = 3, and very much 
so = 4. The STAI scores range from 20 to 80, and they increase 
in response to stress and decrease under relaxing conditions. 
The reliability and validity have been established for use in 
an Indian population.[16]
Hospital anxiety and depression scale
The HADS was used to assess anxiety and depression in the 
participants. This scale was designed to identify cases of 
anxiety disorder (HADS-A) and depression (HADS-D) in 
a nonpsychiatric hospital and clinic patients.[11] The HADS 
has 14 items out of which item numbers 1, 3, 5, 7, 9, 11, 13 
measure anxiety and the remaining items that is, 2, 4, 6, 8, 
10, 12, 14 measure depression. Each item is on a 4-point 
scale, and the scores are added to give a total ranging from 
0 to 21 for anxiety and 0–21 for depression. The reliability 
and validity have been established for use in an Indian 
population.[17]
Yoga practice was ascertained by three questions
For these questions, it was mentioned that yoga practice 
meant the practice of postures (asanas), regulated 
breathing (pranayamas), and meditation, either in combination 
or as a single technique selected out of the three.
Of the three questions, one was a close-ended dichotomous 
question (question 1, below), the second question 
(question 2, below), and the third question were both open 
ended.
The three questions were as follows. Question 1: ‘Are you a 
regular practitioner of yoga?’ Here regular was specified as a 
minimum of 4 days in a week. The options were two, yes or 
no. Question 2 was ‘For how long have you been practicing 
yoga?’(With the option to fill in the number of days, months 
or years).
The third question was 3. For how many minutes/hours do 
you practice yoga daily?
Since this was not a regular questionnaire, but three questions 
with straightforward responses, there was no attempt to 
establish the reliability and validity for these questions.
Results
Linear multiple regression analysis using PASW SPSS 
version 18.0 (Armonk, New York, U.S.) was performed with 
STAI scores (State Trait Anxiety Inventory), HADS-A, and 
HADS-D scores of the HADS as the dependent variables and 
with the duration of yoga practice in months and time spent 
practicing yoga each day as independent variables. Linear 
multiple regression showed that yoga practice in months and 
time spent practicing yoga each day both predicted STAI 
scores (State Trait Anxiety Inventory). The resulting model had 
an adjusted R2 = 0.03 (standard error of the estimate = 11.4), 
df (2,760), F = 11.4, and was significant for yoga practice 
in months at P < 0.001 with 95% CI = (−0.02, −0.05) 
and time spent practicing yoga each day at P = 0.03 
with 95% CI = (−0.01, −0.04] and for HAD‑A, adjusted 
R2 = 0.02 (standard error of the estimate = 4.0), df (2,760), 
F = 8.8, and was significant for yoga practice in months at 
P < 0.01 with 95% CI = (−0.01, −0.01) and time spent practicing 
yoga each day at P < 0.01 with 95% CI = (−0.01, −0.02]. For 
depression scores, the results were different; the duration of 
yoga practice in months alone predicted HAD-D scores and 
the resulting model had an adjusted R2 = 0.01 (standard error 
of the estimate = 3.7), df (2,760), F = 4.6, and was significant 
at P < 0.01 with 95% CI = [−0.01, −0.01], while time spent 
practicing yoga each day did not predict depression scores.
The group mean values (SD) for STAI-state subscale scores, 
HAD-A anxiety scores, and HAD-D depression scores and 
details of the linear multiple regression are given in Table 2.
Discussion
In 763 persons who had a chronic illness, the duration of yoga 
practice in months was associated with lower anxiety and 
depression scores, whereas the time spent practicing yoga each 
day, for at least 4 days in a week was associated with lower 
anxiety scores, but was not associated with the depression scores.
Most studies on the therapeutic benefits of yoga for chronic 
diseases have examined the effects on the quality of life, 
anxiety and depression, in addition to the clinical outcomes.[18] 
In this study, an attempt has been made to understand which 
factor that is, duration or daily intensity of yoga practice has 
a greater effect on the two most common emotional responses 
to chronic illness, anxiety and depression.




Duration of practice in months as predictor Intensity of practice in minutes/day for at 
least 4 days/week as predictor
F df Adjusted R2 β Tolerance 
values
F df Adjusted R2 β Tolerance 
values
STAI‑state subscale 35.5 (11.5) 11.4*** 2760 0.03 −0.2 1.0 11.4* 2760 0.03 −0.1 1.0
HAD‑A 5.3 (4.0) 8.8** 2760 0.02 −0.1 1.0 8.8** 2760 0.02 −0.1 1.0
HAD‑D 5.3 (3.7) 4.6** 2760 0.01 −0.1 1.0 4.6 2760 0.01 0.0 1.0
*P<0.05, **P<0.01, ***P<0.001, linear multiple regression. SD: Standard deviation, STAI: State-Trait Anxiety Inventory, HAD-A: Hospital Anxiety and Depression Anxiety, HAD-D: Hospital 
anxiety and depression-depression
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It is known that anxiety is associated with high rates of 
medically unexplained symptoms and increased utilization 
of healthcare resources.[19-24] In fact, the disability and related 
poor physical and economic outcomes associated with anxiety 
disorders may be as great as with depression.
The neural pathways that process visceral pain also regulate 
the stress response and anxiety.[25] Prolonged anxiety can lead 
to dysregulation of the hypothalamic pituitary axis, as well as 
altered autonomic control with reduced heart rate variability.[26]
The practice of yoga has been found to help in stress 
reduction[9] and in correcting imbalances of the autonomic 
nervous system associated with sympathetic hyperactivity.[27] 
This may explain why yoga practice helps to reduce anxiety 
associated with chronic illness. The amount of time spent 
in practicing yoga each day as well as the duration of yoga 
practice were associated with a reduction in anxiety (HADS) 
and state anxiety.
Depression increases symptom burden and functional 
impairment and also worsens the prognosis for heart disease, 
stroke, diabetes mellitus, HIV/AIDS, cancer and other 
chronic illnesses.[19,28,29] A survey of over 130,000 Canadian 
adults indicated that depression independently increased role 
impairment by 21% compared to healthy persons.[29] When 
depression occurred along with chronic lung disease, diabetes 
mellitus or heart disease, the rate of disability increased by 
over 50%.[29] It is apparent that depression has adverse effects 
on biological mechanisms and self-care in persons who are 
chronically ill.[30-38] The latter includes adherence to diet, 
addictive behavior, taking medication, and exercise, among 
other factors.
Depression is associated with several changes at the synaptic 
level including aminergic reuptake inhibition, presynaptic 
autoregulatory desensitization, up- and down-regulation of 
post synaptor receptor sites and receptor-mediated second 
messenger and neurotrophic intracellular signaling effects.[39-43] 
Neuroimaging studies have identified areas of over‑ and 
under-activity.[44]
The present results show that a long duration of yoga practice 
was associated with lower depression scores in the present 
group of chronically ill persons. The amount of time spent 
practicing each day did not make the same difference.
The inverse relation between physical activity and depression 
is known.[45,46] The therapeutic benefits are particularly 
found if exercise is continued over time.[47] Yoga has a 
physical activity component, in addition to its psychological, 
philosophical (and depending on the program, Spiritual) 
components. Yoga practice has been found beneficial in 
depression.[12] The mechanisms underlying the benefits have 
not been worked out. However, it is possible that among other 
effects, yoga practice acts on neurotransmitters,[48] hence 
acting mainly at the synaptic level. The fact that the changes 
required may involve synaptic receptors[49] in addition to 
hyper/hyposecretion of certain neurotransmitters may explain 
why the duration of yoga practice in months, rather than the 
intensity (as minutes of practice each day) may be associated 
with lower levels of depression associated with chronic illness.
While the findings are of interest as several chronically 
ill people practice yoga, it has the following limitations: 
(i) The study may not prove a causative effect; rather it shows 
strong association between intensity and duration of yoga on 
anxiety and depression associated with chronic illness (ii) there 
was no attempt to assess the impact of the frequency of yoga 
practice; instead persons were considered regular practitioners 
if they practiced yoga for at least 4 days in a week. (iii) Other 
factors such as the severity of illness, social support, and 
personality traits could influence the level of anxiety and 
depression experienced by a person with chronic illness. Also, 
the same factors could influence the intensity and duration of 
yoga practice. However looking at these factors was not the 
aim of the present study. (iv) The participants varied widely 
in their age, severity of disease and other social factors. 
(v) Yoga practice included yoga postures (asanas), breathing 
techniques (pranayamas) and meditation. There was no attempt 
to differentiate between different schools of yoga or amount of 
time spent practicing the different techniques. Also, there was 
no attempt to ask the participants about whether they practiced 
yoga cleansing practices (yoga kriyas), yoga physiological 
‘locks’ (bandhas) and followed a yoga lifestyle. (vi) There 
was no attempt to look at other aspects of emotional distress, 
other than anxiety and depression. (vii) Approximately 30% of 
the participants returned one of the questionnaires incorrectly 
filled in and hence had to be excluded.
Despite these limitations, some of which suggest directions 
for future study, the present results suggest that the duration 
and intensity of yoga practice are associated with a decrease 
in anxiety and depression associated with chronic illness.
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